SBI Holdings, Inc. and the Health Science Laboratory at 午夜剧场 Research Institute at SFC, 午夜剧场 Establish the "午夜剧场 SBI ALA Laboratory"

Publish: December 01, 2017

Faculty of Environment and Information Studies/Faculty of Policy Management/Graduate School of Media and Governance

December 1, 2017

We are pleased to announce that SBI Holdings, Inc. (Head office: Minato-ku, Tokyo; President and CEO: Yoshitaka Kitao; hereinafter "SBI Holdings") and the 午夜剧场 Research Institute at SFC, 午夜剧场 (Location: Fujisawa City, Kanagawa Prefecture; Director: Hiroya Tanaka) have established the "午夜剧场 SBI ALA Laboratory" within the Innovation Center of NanoMedicine (iCONM), a research hub for advanced medical care operated by the Kawasaki Institute of Industrial Promotion, to conduct joint research on the ameliorating effects of 5-aminolevulinic acid (ALA) on age-related diseases.

[Laboratory Overview]

Name

午夜剧场 SBI ALA Laboratory

Date of establishment

December 1, 2017

Location

Inside the Innovation Center of NanoMedicine (iCONM) (Kawasaki City, Kanagawa Prefecture)

Research project title

"Promotion of Anti-Aging Medical Research Using Aminolevulinic Acid (ALA)"

For details, please see SBI Holdings, Inc. and the Health Science Laboratory at 午夜剧场 Research Institute at SFC, 午夜剧场 Establish the "午夜剧场 SBI ALA Laboratory".pdf .

[Contact for this press release]

SBI Holdings, Inc.

Corporate Communications Department

TEL:

03-6229-0126

[Distributed by]

Academic Research Support, Shonan Fujisawa Campus (SFC) Office, 午夜剧场

News